Inventor · disambiguated record
Shobu Odate
Also filed as: ODATE SHOBU
5 granted patents·10 pending applications·3 citations·filing 2019–2025
69Inventor score
Top patents by PatentIndex Score
15 records- 0189US11795460B2Compositions and methods for TTR gene editing and treating ATTR amyloidosisINTELLIA THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·24 claims
- 0283US11549107B2Compositions and methods for treating alpha-1 antitrypsin deficiencyINTELLIA THERAPEUTICS INC·Filed 2019·Granted Jan 10, 2023·2 cites·21 claims
- 0381US2025207130A1Compositions and Methods for TTR Gene Editing and Treating ATTR AmyloidosisINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0477US11965165B2Compositions and methods for TTR gene editing and treating ATTR amyloidosisINTELLIA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·21 claims
- 0577US2024018496A1Compositions and Methods for Kallikrein (KLKB1) Gene EditingINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0673US12460205B2Compositions and methods for treating alpha-1 antitrypsin deficiencyINTELLIA THERAPEUTICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·18 claims
- 0772US2023295587A1Compositions and Methods for Kallikrein (KLKB1) Gene EditingINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0871US2024124897A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0970US12480109B2Compositions and methods for kallikrein (KLKB1) gene editingINTELLIA THERAPEUTICS INC·Filed 2025·Granted Nov 25, 2025·0 cites·27 claims
- 1064US2025099621A1Systemic administration of circular rna polynucleotides encoding muscle proteins or protein complexesORNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1163US2020248180A1Compositions and Methods for TTR Gene Editing and Treating ATTR AmyloidosisINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1262US2023044994A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1357US2021222173A1Compositions and Methods for Lactate Dehydrogenase (LDHA) Gene EditingINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1455US2023035659A1Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use ThereofINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1555US2021163943A1Compositions and Methods for Hydroxyacid Oxidase 1 (HAO1) Gene Editing for Treating Primary Hyperoxaluria Type 1 (PH1)INTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shobu Odate files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →